Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Multitude Therapeutics Inc.
Condition: Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07590531
AMT-116 in Combination With Ivosidan in Patients With Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.